India · Delayed Price · Currency is INR NSE:QMSMEDI Statistics
Total Valuation
NSE:QMSMEDI has a market cap or net worth of INR 1.73 billion. The enterprise value is 2.51 billion.
| Market Cap | 1.73B |
| Enterprise Value | 2.51B |
Important Dates
The last earnings date was Saturday, May 30, 2026.
| Earnings Date | May 30, 2026 |
| Ex-Dividend Date | Sep 22, 2025 |
Share Statistics
NSE:QMSMEDI has 17.85 million shares outstanding. The number of shares has increased by 5.12% in one year.
| Current Share Class | 17.85M |
| Shares Outstanding | 17.85M |
| Shares Change (YoY) | +5.12% |
| Shares Change (QoQ) | +81.60% |
| Owned by Insiders (%) | 73.67% |
| Owned by Institutions (%) | n/a |
| Float | 4.70M |
Valuation Ratios
The trailing PE ratio is 17.96.
| PE Ratio | 17.96 |
| Forward PE | n/a |
| PS Ratio | 1.00 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 2.49 |
| P/FCF Ratio | 12.68 |
| P/OCF Ratio | 8.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.69, with an EV/FCF ratio of 18.37.
| EV / Earnings | 24.75 |
| EV / Sales | 1.45 |
| EV / EBITDA | 9.69 |
| EV / EBIT | 11.43 |
| EV / FCF | 18.37 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.65.
| Current Ratio | 1.56 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 2.88 |
| Debt / FCF | 5.46 |
| Interest Coverage | 3.35 |
Financial Efficiency
Return on equity (ROE) is 10.78% and return on invested capital (ROIC) is 8.67%.
| Return on Equity (ROE) | 10.78% |
| Return on Assets (ROA) | 6.81% |
| Return on Invested Capital (ROIC) | 8.67% |
| Return on Capital Employed (ROCE) | 18.04% |
| Weighted Average Cost of Capital (WACC) | 7.75% |
| Revenue Per Employee | 19.42M |
| Profits Per Employee | 1.14M |
| Employee Count | 89 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, NSE:QMSMEDI has paid 45.23 million in taxes.
| Income Tax | 45.23M |
| Effective Tax Rate | 27.51% |
Stock Price Statistics
The stock price has increased by +12.99% in the last 52 weeks. The beta is 0.74, so NSE:QMSMEDI's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +12.99% |
| 50-Day Moving Average | 85.25 |
| 200-Day Moving Average | 89.53 |
| Relative Strength Index (RSI) | 66.48 |
| Average Volume (20 Days) | 13,200 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:QMSMEDI had revenue of INR 1.73 billion and earned 101.32 million in profits. Earnings per share was 5.40.
| Revenue | 1.73B |
| Gross Profit | 802.50M |
| Operating Income | 219.38M |
| Pretax Income | 164.40M |
| Net Income | 101.32M |
| EBITDA | 258.78M |
| EBIT | 219.38M |
| Earnings Per Share (EPS) | 5.40 |
Balance Sheet
The company has 66.60 million in cash and 744.81 million in debt, with a net cash position of -678.21 million or -37.99 per share.
| Cash & Cash Equivalents | 66.60M |
| Total Debt | 744.81M |
| Net Cash | -678.21M |
| Net Cash Per Share | -37.99 |
| Equity (Book Value) | 1.14B |
| Book Value Per Share | 29.67 |
| Working Capital | 507.45M |
Cash Flow
In the last 12 months, operating cash flow was 194.37 million and capital expenditures -57.87 million, giving a free cash flow of 136.50 million.
| Operating Cash Flow | 194.37M |
| Capital Expenditures | -57.87M |
| Depreciation & Amortization | 39.39M |
| Net Borrowing | -24.74M |
| Free Cash Flow | 136.50M |
| FCF Per Share | 7.65 |
Margins
Gross margin is 46.42%, with operating and profit margins of 12.69% and 5.86%.
| Gross Margin | 46.42% |
| Operating Margin | 12.69% |
| Pretax Margin | 9.51% |
| Profit Margin | 5.86% |
| EBITDA Margin | 14.97% |
| EBIT Margin | 12.69% |
| FCF Margin | 7.90% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.52%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.52% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.81% |
| Buyback Yield | -5.12% |
| Shareholder Yield | -4.60% |
| Earnings Yield | 5.85% |
| FCF Yield | 7.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |